Skip to main content
ES
v1.2
Log in
S

Syngene Intl

SYNGENE INTLNSE
₹361+0.00 (+0.00%)
Market Cap
₹15,517Cr.
P/E Ratio
52.4
P/B Ratio
3.01
EPS (TTM)
₹6.89
Div Yield
0.35%
ROCE
9.99%
ROE
7.78%
52W Low: ₹34452W High: ₹679
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 5.0% a year over three years.
  • Debt is 0.09× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Syngene_Intl — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
4.3/ 10Overall
3/ 10Valuation
5/ 10Quality
5/ 10Fundamental
4/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 52.4P/E: 52.4 | P/B: 3.01
Growth
ModestSales CAGR — 3Y: 5% · 1Y: -3%
Profitability
Low MarginROCE: 9.99% | ROE: 7.78%

Key Metrics

Valuation
Price / Sales 4.31x
Price / FCF 28.4x
Book Value ₹120
Margins & returns
Operating Margin 22%
Net Margin 6.1%
Return on Assets 3.1%

Frequently Asked Questions

MarketsPortfolioChart